SCHRODER INVESTMENT MANAGEMENT GROUP
Position in NBIX — Neurocrine Biosciences Inc
CIK 1086619
London, X0
Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,739,280
-$6,707,927 QoQ
Shares Held
16,253
-77.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#276
of 768 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $225,719,959 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,280,484 | $77,262,797 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
72,306 | $39,177,559 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
1,129,781 | $39,169,506 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
1,618,404 | $23,450,672 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
368,017 | $17,116,470 | |
| 6 | HCM |
HUTCHMED (China) Ltd
|
1,477,494 | $15,897,835 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
333,656 | $8,211,273 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
16,253 | $2,739,280 |
All Filings in NBIX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,739,280 | 16,253 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,447,207 | 71,711 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $12,342,897 | 87,026 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $393,204 | 2,801 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,636,463 | 28,932 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,288,691 | 29,735 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $17,299,327 | 126,735 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $24,342,989 | 211,274 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $25,521,815 | 185,384 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $20,705,515 | 150,127 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,952,491 | 75,535 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,480,449 | 57,604 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,968,529 | 63,293 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,652,327 | 55,842 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $849,576 | 7,113 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,107,981 | 10,432 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||